Researchers develop calculator to better determine prognosis for patients with melanoma

Tool provides physicians with better understanding of survival rates to help patients make more informed treatment decisions

The following stories detail news from the current issue of Mayo Clinic Proceedings. They are intended for use as individual stories or as part of a larger story on a particular medical topic.

Mayo Clinic researchers have developed another user-friendly calculator to aid physicians in better understanding complex cancer data and helping their patients make more informed decisions about treatment.

An article about the newest calculator — to determine the baseline prognosis for patients newly-diagnosed with melanoma, an often fatal cancer of the skin, and the potential benefits for such patients of receiving interferon therapy after surgery — appears in the current issue of Mayo Clinic Proceedings. The calculator is developed by Mayo Clinic researchers Charles Loprinzi, M.D., Stephen Thome, M.D., and Mike Heldebrant, Ph.D. candidate.

Two years ago these investigators created a similar calculator to help physicians provide breast cancer patients with survival estimates for each treatment option after surgery. Their intent with both calculators has been to further educate and empower physicians and patients by offering an easy-to-use tool for accessing accurate and understandable information about survival rates and treatment options.

“It’s important for physicians to help patients understand their baseline prognosis, their chances of cure from surgery alone, the potential benefits ascribed to other treatments and the risks of the cancer recurring,” says Dr. Loprinzi, a Mayo Clinic oncologist. “We know that most cancer patients want this information for their own knowledge, and to be able to actively discuss and decide with their physicians the most appropriate course of treatment for them.”

Researchers used findings from a previously published surgical database of 17,600 patients and information about the potential benefits from interferon treatments to develop a mathematical formula for calculating individual prognostic information for patients with resected melanoma. Five data items about the primary tumor and the regional lymph nodes are entered into the calculator. The computer then uses the mathematical formula to compute the patient’s potential of living in five years with no recurring cancer if no additional therapy is given. It also calculates the patient’s potential of living five years after undergoing surgery and interferon therapy.

Additional contact information:
John Murphy
507-284-5005 (days)
507-284-2511 (evenings)
e-mail: newsbureau@mayo.edu(/A>

Media Contact

John Murphy EurekAlert!

Weitere Informationen:

http://www.mayo.edu/

Alle Nachrichten aus der Kategorie: Health and Medicine

This subject area encompasses research and studies in the field of human medicine.

Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.

Zurück zur Startseite

Kommentare (0)

Schreib Kommentar

Neueste Beiträge

New machine learning tool tracks urban traffic congestion

UBER driver data helps track and potentially alleviate urban traffic congestion. A new machine learning algorithm is poised to help urban transportation analysts relieve bottlenecks and chokepoints that routinely snarl…

Voyager spacecraft detect new type of solar electron burst

Physicists report accelerated electrons linked with cosmic rays. More than 40 years since they launched, the Voyager spacecraft are still making discoveries. In a new study, a team of physicists…

Cooling electronics efficiently with graphene-enhanced heat pipes

Researchers at Chalmers University of Technology, Sweden, have found that graphene-based heat pipes can help solve the problems of cooling electronics and power systems used in avionics, data centres, and…

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close